Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CNTA | US
-0.32
-1.97%
Healthcare
Biotechnology
30/06/2024
04/10/2024
15.94
15.97
16.30
15.57
Centessa Pharmaceuticals plc a clinical-stage pharmaceutical company discovers develops and delivers medicines to patients. Its pipeline products include SerpinPC an activated protein C inhibitor which is in Phase IIa clinical development for the treatment of hemophilia A and B; and ORX750 an orally administered OX2R agonist for the treatment of NT1 with potential expansion into other sleep disorders. The company also develops LB101 a PD-L1xCD47 LockBody which is designed to selectively drive potent CD47 and CD3 effector function activity while avoiding systemic toxicity; ZF874 in alpha-1 antitrypsin deficiency a dual-STAT3/5 degrader program in acute myeloid leukemia (AML); MGX292 a protein-engineered variant of human bone morphogenetic protein 9 (BMP9) for the treatment of pulmonary arterial hypertension (PAH); and OX2R Agonists compounds are currently in development for the treatment of narcolepsy including TAK-861. In addition its products pipeline comprises CBS001 a neutralizing therapeutic mAb to the inflammatory membrane form of LIGHT for inflammatory / fibrotic diseases; and CBS004 a therapeutic mAb targeting BDCA-2 for the potential treatment of autoimmune diseases as well as earlier-stage preclinical assets including ORX750 an orally administered selective orexin receptor-2 (OX2R) agonist for the treatment of narcolepsy and other sleep disorders; and discovery-stage programs in certain other disease areas. Centessa Pharmaceuticals plc was incorporated in 2020 and is based in Altrincham the United Kingdom.
View LessPositive Momentum
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
66.4%1 month
81.2%3 months
69.3%6 months
62.8%-
-
7.07
0.30
0.21
1.12
265.71
-
-155.10M
2.05B
2.05B
-
-2.27K
-
-
-55.84
1.64
1.69
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
2.24
Range1M
4.65
Range3M
9.13
Rel. volume
0.23
Price X volume
3.88M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Novavax Inc | NVAX | Biotechnology | 13.61 | 2.18B | -7.29% | n/a | -54.03% |
Vericel Corporation | VCEL | Biotechnology | 43.36 | 2.17B | 6.54% | 4.32K | 39.42% |
Akero Therapeutics Inc | AKRO | Biotechnology | 28.24 | 2.04B | -3.32% | n/a | 4.54% |
Celldex Therapeutics Inc | CLDX | Biotechnology | 30.65 | 2.03B | 1.46% | n/a | 0.29% |
Harmony Biosciences Holdings Inc. | HRMY | Biotechnology | 34.6 | 2.00B | -2.73% | 20.07 | 40.71% |
Maravai LifeSciences Holdings Inc | MRVI | Biotechnology | 7.89 | 1.99B | -0.13% | n/a | 128.60% |
Ligand Pharmaceuticals Incorporated | LGND | Biotechnology | 104.78 | 1.95B | 4.83% | 42.52 | 0.98% |
BEAM THERAPEUTICS INC. | BEAM | Biotechnology | 23.41 | 1.93B | -0.38% | n/a | 19.35% |
Galapagos NV | GLPG | Biotechnology | 29.19 | 1.92B | 2.89% | 55.25 | 0.00% |
Mirum Pharmaceuticals Inc | MIRM | Biotechnology | 39.26 | 1.87B | -5.37% | n/a | 138.24% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Fox Factory Holding Corp | FOXF | Recreational Vehicles | 40.42 | 1.68B | 0.17% | 42.66 | 64.69% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 57.84 | 1.66B | 0.98% | 21.48 | 56.33% |
Steelcase Inc | SCS | Building Products & Equipment | 12.97 | 1.47B | 0.78% | 12.50 | 65.47% |
REV Group Inc | REVG | Recreational Vehicles | 27.56 | 1.43B | 0.00% | 6.15 | 63.13% |
Janus International Group Inc. | JBI | Building Products & Equipment | 9.79 | 1.42B | 2.73% | 11.54 | 116.21% |
Pitney Bowes Inc | PBI | Building Products & Equipment | 6.92 | 1.24B | 1.91% | n/a | -571.93% |
ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 11.47 | 1.15B | 0.09% | n/a | 19.46% |
Camping World Holdings Inc | CWH | Recreational Vehicles | 23.44 | 1.06B | -0.38% | n/a | 3644.76% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 39.7 | 793.63M | -0.68% | n/a | 1.50% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.64 | 767.43M | 0.00% | 61.27 | 77.00% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 1.12 | 0.76 | Expensive |
Ent. to Revenue | 265.71 | 3,674.48 | Cheaper |
PE Ratio | - | 38.01 | - |
Price to Book | 7.07 | 14.10 | Cheaper |
Dividend Yield | - | 2.22 | - |
Std. Deviation (3M) | 69.34 | 74.67 | Par |
Debt to Equity | 0.30 | -1.82 | Expensive |
Debt to Assets | 0.21 | 0.26 | Par |
Market Cap | 2.05B | 3.73B | Emerging |